Reproductive Health and Menstrual Disorders

REPRODUCTIVE HEALTH AND MENSTRUAL DISORDER VOCABULARY

• Core Vocabulary (Box 4.1):     * meno: Related to menstruation.     * metro: Derived from time.     * oligo: Meaning few.     * a: Indicating without, none, or a lack of.     * rhagia: Denoting excess or abnormal flow/discharge.     * dys: Meaning not or pain.     * rhea: Meaning flow.

• Common Women's Reproductive Disorders:     * Menstrual disorders.     * Infertility.     * Contraception.     * Abortion.     * Menopause.

• Common Menstrual Disorders:     * Amenorrhea.     * Dysmenorrhea.     * Dysfunctional uterine bleeding (DUB).     * Premenstrual syndrome (PMS).     * Premenstrual dysphoric disorder (PMDD).     * Endometriosis.

THE MENSTRUAL CYCLE: OVARIAN AND UTERINE PHASES

• Ovarian Cycle Phases:     * Follicular Phase: Occurs from days $1$ to $14$. Involves the developing follicle and the mature follicle.     * Ovulation: Occurs at approximately day $14$.     * Luteal Phase: Occurs from days $14$ to $28$. Features the corpus luteum and eventual regressive corpus luteum.

• Hormonal Concentration (Plasma):     * Pituitary Gland Secretions:         * FSH (Follicle-Stimulating Hormone): Peaks during the follicular phase to stimulate follicle growth.         * LH (Luteinizing Hormone): Sharp peak triggers ovulation at day $14$.     * Ovarian Hormones:         * Estrogen: High levels during the late follicular phase and mid-luteal phase.         * Progesterone: Low during follicular phase; rises significantly during the luteal phase, secreted by the corpus luteum.

• Uterine (Endometrial) Cycle:     * Menstruation: Occurs during the first $1$ to $7$ days approximately.     * Proliferative Phase: Alignment with the follicular phase; the endometrium rebuilds.     * Secretory Phase: Alignment with the luteal phase; the endometrium prepares for potential implantation.

AMENORRHEA: TYPES, ETIOLOGY, AND MANAGEMENT

• Definition: The absence of menses during reproductive years.

• Primary Amenorrhea:     * Type 1: Absence of menses by age $14$ accompanied by an absence of the development of secondary sexual characteristics.     * Type 2: Absence of menses by age $16$ with normal development of secondary sexual characteristics.

• Secondary Amenorrhea: The absence of regular menses for $3$ cycles or irregular menses for $6\,\text{months}$ in women who have previously menstruated regularly.

• Therapeutic Management:     * Primary: Involves correcting underlying disorders and administering estrogen replacement therapy.     * Secondary: Includes cyclic progesterone, treatment of hyperprolactinemia, addressing eating disorders, treating obesity, and managing hypothalamic failure or hypothyroidism.

• Nursing Assessment:     * Evaluation of Tanner stages of breast development.     * Laboratory testing.

• Nursing Management: Adherence to Teaching Guidelines $4.2$.

DYSMENORRHEA: ETIOLOGY AND CLINICAL MANAGEMENT

• Definition: Painful menstruation.

• Types and Etiology:     * Primary (Spasmodic): Caused by increased prostaglandin production.     * Secondary (Congestive): Caused by pelvic or uterine pathology. Endometriosis is the most common cause of secondary dysmenorrhea.

• Nursing Assessment Findings:     * History: Past medical history, sexual history, and menstrual history.     * Examination: Bimanual pelvic examination.     * Physical Manifestations: Pain, nausea, vomiting, diarrhea, fatigue, fever, headache, dizziness, bloating, water retention, weight gain, muscle aches, food cravings, and breast tenderness.

• Teaching Guidelines 4.3 (Tips for Managing Dysmenorrhea):     * Exercise: Increases endorphins and suppresses prostaglandin release.     * Nutrition: Limit salty foods to prevent fluid retention; increase fiber (fruits/vegetables) to prevent constipation.     * Hydration: Increase water consumption to act as a natural diuretic; sip warm beverages like decaffeinated green tea.     * Comfort Measures: Heating pads, warm baths, or warm showers to promote relaxation.     * Positioning: Keep legs elevated while lying down or lie on the side with knees bent (fetal position).     * Stress Management: Practice relaxation techniques and stress reduction to cope with pain.     * Avoidance: Stop smoking and decrease alcohol use to prevent vasoconstriction.

ABNORMAL UTERINE BLEEDING (AUB)

• Definition: Painless endometrial bleeding that is prolonged, excessive, and irregular, not attributed to any underlying structural or systemic disease.

• Characteristics:     * Similar to and may overlap other uterine bleeding disorders.     * Occurs most frequently at the beginning and the end of reproductive years.     * Etiology: Related to hormonal disturbances.

• Therapeutic Management Goals:     * Normalize bleeding and correct anemia.     * Prevent or diagnose early cancer.     * Restore quality of life.

• Interventions:     * Pharmacotherapy: Potential insertion of a hormone-secreting intrauterine system.     * Surgical Intervention: Dilation and curettage (D&C), endometrial ablation, uterine artery embolization, or hysterectomy.

• Nursing Management: Client education and implementation of Nursing Care Plan $4.1$.

PREMENSTRUAL SYNDROME (PMS) AND PREMENSTRUAL DYSPHORIC DISORDER (PMDD)

• Premenstrual Syndrome (PMS): A wide range of recurrent symptoms with an unknown etiology.

• Premenstrual Dysphoric Disorder (PMDD): A more severe variant of PMS; mood disorders are the main symptoms.

• Symptom Categorization (ACDHO):     * A: Anxiety.     * C: Craving.     * D: Depression.     * H: Hydration.     * O: Other.     * Note: Irritability, tension, and dysphoria are the most prominent and consistent symptoms.

• Treatment Options (Box 4.2):     * Lifestyle: Stress reduction, exercise $3$ to $5$ times a week, balanced diet, increased water, decreased caffeine, smoking cessation, alcohol limitation, and support groups.     * Vitamin/Mineral Supplements:         * Multivitamin daily.         * Vitamin E: $400\,\text{units}$ daily.         * Calcium: $1,200$ to $1,600\,mg$ daily.         * Magnesium: $200$ to $400\,mg$ daily.     * Medications:         * NSAIDs (taken a week prior to menses).         * Oral contraceptives (low dose).         * Antidepressants (SSRIs).         * Anxiolytics (taken during the luteal phase).         * Diuretics for fluid removal.         * Progestins.         * GnRH agonists.         * Danazol (androgen hormone that inhibits estrogen production).

ENDOMETRIOSIS

• Definition and Etiology: Presence of endometrial tissue outside the uterus; exact cause is unknown.

• Staging/Grades:     * Grade I: Minimal endometriosis.     * Grade II: Mild endometriosis.     * Grade III: Moderate endometriosis.     * Grade IV: Severe endometriosis.

• Nursing Assessment Factors:     * Infertility and pain.     * Nonspecific pelvic tenderness.     * Tender nodular masses located on uterosacral ligaments, posterior uterus, or posterior cul-de-sac.

• Management:     * Therapeutic: Surgery and medication therapy.     * Nursing: Education on healthy lifestyle habits and referral to support groups.

INFERTILITY ASSESSMENT AND TREATMENT

• Classifications: Primary or secondary infertility.

• Factors: Impact of culture, ethnicity, religion, and expectations for reproduction. Risk factors exist for both males and females.

• Male Factor Assessment: Semen analysis, sexual characteristics, external and internal reproductive organ examination, and digital prostate examination.

• Female Factor Assessment: Ovarian function, pelvic organs, ovulation predictor kits, clomiphene citrate challenge test, hysterosalpingogram, and laparoscopy.

• Selected Treatment Options (Table 4.3):     * Clomiphene citrate (Clomid): Nonsteroidal synthetic antiestrogen to induce ovulation; usually discontinued after $3$ cycles. Nursing consideration: advise intercourse every other day for $1\,\text{week}$ after day $5$ of medication.     * Human menopausal gonadotropin (hMG) (Pergonal): Induces ovulation by direct stimulation of ovarian follicles.     * Artificial Insemination: Insertion of semen into the cervical os or uterine cavity. Partner or donor sperm may be used.     * In vitro fertilization (IVF): Oocytes fertilized in a lab and transferred to the uterus; indicated for tubal obstruction, endometriosis, or low sperm count.     * Gamete intrafallopian transfer (GIFT): Oocytes and sperm combined and placed in the fallopian tube. Requires laparoscopy and general anesthesia.     * Intracytoplasmic sperm injection (ICSI): One sperm injected into the cytoplasm of the oocyte; used for male factor infertility.     * Donor oocytes/sperm: Inseminated eggs/sperm transferred via IVF; recommended for women over $40\,\text{years old}$ or poor-quality eggs.     * Preimplantation genetic diagnosis (PGD): Genetic testing of embryos before pregnancy when parents have known abnormalities.     * Gestational carrier (Surrogacy): Laboratory fertilization with embryos transferred to another woman. Involves complex medical-legal issues.

• Nursing Management: Respect for the couple, education, anticipatory guidance, stress management, counseling, advocacy, and assistance with financial strategies.

CONTRACEPTION METHODS AND NURSING CARE

• Behavioral Methods: Abstinence, fertility awareness (cervical mucus, basal body temperature, symptothermal, standard days), withdrawal (coitus interruptus), and lactational amenorrhea method.

• Barrier Methods (Effectiveness):     * External Condom: Perfect use $98\%$, Typical use $87\%$.     * Internal Condom: Perfect use $95\%$, Typical use $79\%$.     * Diaphragm: $88\%$ effective.     * Cervical Cap: $77\%$ to $83\%$ effective.     * Contraceptive Sponge: $76\%$ to $88\%$ effective.

• Hormonal Methods: Oral contraceptives, injectables, transdermal patches, vaginal rings, implantable contraceptives, intrauterine contraceptives, and emergency contraception.

• Sterilization:     * Tubal Ligation (Women): Fallopian tubes are grasped and sealed via laparoscope.     * Vasectomy (Men): Cutting of the vas deferens under local anesthesia.

• Nursing Assessment and Intervention:     * Detailed history (Medical, Family, OB/GYN, Personal), physical exam, and diagnostic testing.     * Client education regarding mechanism of action, advantages/disadvantages, danger signs, and backup methods.

ABORTION TYPES AND PROCEDURES

• Clinical Types of Abortion:     * Threatened.     * Imminent.     * Complete.     * Incomplete.     * Missed.     * Habitual.

• Direct Methods:     * Medical Abortion:         * Methotrexate followed by misoprostol.         * Mifepristone followed by misoprostol.     * Surgical Abortion.

MENOPAUSE AND ITS SYSTEMIC IMPACT

• Impact on the Body:     * Brain: Hot flashes; disturbances in sleep, mood, and memory.     * Heart: Lower levels of HDL (High-Density Lipoprotein); increased risk of cardiovascular disease (CVD).     * Bones: Loss of bone density; increased risk of osteoporosis.     * Breasts: Breast duct and gland tissue are replaced by fat.     * Genitourinary: Vaginal dryness, stress incontinence, and cystitis.     * Gastrointestinal: Decreased Calcium ($Ca+$) absorption; increased risk of fractures.     * Skin: Becomes dry and thin; collagen levels decrease.

• Nursing Assessment during Menopausal Transition:     * Screening for osteoporosis, CVD, and cancer risk.     * Lifestyle planning to prevent chronic conditions.

• Nursing Management: Health maintenance education, risk reduction, lifestyle modifications, and stress management.